http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103145608-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 |
| filingDate | 2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103145608-B |
| titleOfInvention | Anti-enteric virus71 (EV71) hexanolactam compounds and its production and use |
| abstract | A kind of hexanolactam class enteric virus71 (EV71) HRV 3CP inhibitor, its general structure is for shown in compound (M), each variable in structure defines in the description, and these compounds effectively suppress or blocked copying of enteric virus71.The present invention relates to the compound containing formula (M) structure, its various optical isomer, the metabolite of pharmaceutical activity, pharmacologically acceptable salt, solvate and prodrug to catch the discovery of antiviral and application at preparation treatment hand foot mouth disease poison.The invention still further relates to intermediate and the synthetic method of preparation formula (M) structural compounds. |
| priorityDate | 2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.